Kelvin C. de Andrade

Specifications of the ACMG/AMP variant interpretation guidelines for germline <i>TP53</i> variants

Cristina Fortuño, Kristy Lee, Magali Olivier et al. · Human Mutation · 2020 · 165 citations · Full text

Life Sciences, Genetics, Oncology +17

The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute

Kelvin C. de Andrade, Elaine E. Lee, Elise M. Tookmanian et al. · Cell Death and Differentiation · 2022 · 165 citations · Full text

Medicine, Cancer Biology, Oncology +14

Variable population prevalence estimates of germline <i>TP53</i> variants: A gnomAD-based analysis

Kelvin C. de Andrade, Megan N. Frone, Talía Wegman-Ostrosky et al. · Human Mutation · 2018 · 95 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Fundamental immune–oncogenicity trade-offs define driver mutation fitness

David Hoyos, Roberta Zappasodi, Isabell Schulze et al. · Nature · 2022 · 81 citations · Full text

Medicine, Cancer Biology, Molecular Biology +17

Higher-than-expected population prevalence of potentially pathogenic germline<i>TP53</i>variants in individuals unselected for cancer history

Kelvin C. de Andrade, Douglas R. Stewart, Eric Karlins et al. · Human Mutation · 2017 · 63 citations

Life Sciences, Genetics, Molecular Genetics +17